Sunshield Chemicals Limited has successfully concluded its rights issue, marking a significant corporate action for the company. The rights issue, which opened on September 30, 2025, and closed on October 24, 2025, saw the allotment of 14,41,776 fully paid-up equity shares.

Rights Issue Details

The Rights Issue Committee of Sunshield Chemicals approved the allotment of shares on October 27, 2025. Here are the key details of the issue:

Impact on Share Capital

The successful completion of the rights issue has led to an increase in the company's paid-up equity share capital. The changes in the share capital structure are as follows:

Regulatory Compliance

The basis of allotment was finalized in consultation with Bigshare Services Private Limited, the registrar to the issue, and approved by BSE Limited, the designated stock exchange for the issue. This process ensures compliance with regulatory requirements and transparency in the allotment process.

Significance for Investors

This rights issue provides existing shareholders with an opportunity to increase their stake in the company proportionately. The infusion of additional capital through this issue may potentially be used for various corporate purposes, which could include expansion plans, debt reduction, or working capital requirements.

Investors and market participants should note that this corporate action may have implications for the company's financial structure and future growth prospects. However, the specific use of proceeds and its impact on the company's operations would require further information from the management.

As always, investors are advised to conduct their own research and consider their financial goals before making investment decisions based on this corporate action.

Sunshield Chemicals Limited has unveiled the terms of its upcoming rights issue, following approval from BSE Limited on September 12, 2025. The company aims to raise Rs. 129.90 crore through the issuance of fully paid-up equity shares, offering existing shareholders an opportunity to increase their stake in the company.

Rights Issue Details

Key Dates

Fractional and Zero Entitlements

Sunshield Chemicals has outlined specific provisions for fractional entitlements and shareholders with less than 6 shares:

1. Shareholders with less than 51 shares or holdings not in multiples of 51 will have fractional entitlements ignored in the Rights Entitlement computation.
2. These shareholders will receive preferential consideration for the allotment of one additional equity share if they apply for additional shares beyond their Rights Entitlement.
3. Shareholders holding less than 6 shares as of the Record Date will have zero entitlement but can apply for additional shares with preferential consideration for one additional share.

Additional Information

• The entire issue price of Rs. 901.00 per share is payable at the time of application.
• The Rights Issue Committee has the authority to extend the closing date, provided the issue period does not exceed 30 days from the opening date.
• The ISIN for dematerialized rights entitlement is INE199E20014.

Sunshield Chemicals Limited has stated that further details of the rights issue will be included in the Letter of Offer, which will be filed with the Securities and Exchange Board of India and BSE Limited.

This rights issue presents an opportunity for existing shareholders to increase their stake in Sunshield Chemicals Limited, while also allowing the company to raise significant capital for its operations and growth initiatives.